Skip to main content
NC3Rs | 20 Years: Pioneering Better Science

Search our portfolio

Use the filters below to identify NC3Rs projects relevant to your work by R, topic, model or activity type. If you are looking for something specific, you can add keyword(s) into the search box.

418 results

Over the last fourteen years, Dr Meri Huch has built a career developing organoids to study human organs in health and disease. This includes developing the first human liver organoids for preclinical research, most notably enabling liver cancer to be studied in vitro.

Headshot of Dr Meritxell Huch

The research team of Professors Bazbek Davletov and Andrew Peden, long-term collaborators at the University of Sheffield, have developed in vitro, cell-based assays for replacing animal testing in the manufacture of clostridial toxin-based medical products.

Professor Andrew Peden standing with his research group

With a decade of NC3Rs funding, scientists at the University of Birmingham have developed the first mature bone organotypic model, then systematically adapted and modified it to replace the use of rodents across a range of therapeutic areas involving the study of bone growth and regeneration.

Dr Alexandra Iordachescu and Dr Liam Grover discuss an organotypic bone model

Professor Anthony Chalmers and Co-Investigator Dr Natividad Gomez-Roman have further developed a 3D human cell culture model replacing the use of mice to evaluate and screen treatments for Glioblastoma (GBM).

A group of researchers stand smiling on a sunny day after having paused on a bike ride.

Dr Alan Harper and NC3Rs-BHF PhD student Jacob Ranjbar have developed an artificial human blood vessel to study blood clotting in vitro and replace the use of mice in thrombosis research. They have successfully disseminated the model to the thrombosis community, including for new applications within cardiovascular research.

Portrait of Dr Alan Harper and Dr Jacob Ranjbar